BamSEC and AlphaSense Join Forces
Learn More

Melt Pharmaceuticals, Inc. – Material Contracts

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.23
from S-1 4 pages Release Agreement
12/34/56
EX-10.22
from S-1 4 pages February 18, 2022 via Email: [***]
12/34/56
EX-10.21
from S-1 12 pages April 29, 2019 Mark Hazard [***] [***] Re: Employment Terms
12/34/56
EX-10.20
from S-1 16 pages September 27, 2018 Greg Madison [***] [***] Re: Employment Terms 1. Effectiveness
12/34/56
EX-10.19
from S-1 3 pages June 17, 2021 via Email: [***]
12/34/56
EX-10.18
from S-1 9 pages Royalty Agreement
12/34/56
EX-10.17
from S-1 6 pages Management Services Agreement
12/34/56
EX-10.16
from S-1 3 pages Right of First Refusal Agreement
12/34/56
EX-10.15
from S-1 4 pages Trademark Security Agreement
12/34/56
EX-10.14
from S-1 4 pages Patent Security Agreement
12/34/56
EX-10.12
from S-1 42 pages Recitals
12/34/56
EX-10.5
from S-1 7 pages Melt Pharmaceuticals, Inc. Non-Employee Director and Officer Restricted Stock Unit Grant Notice
12/34/56
EX-10.4
from S-1 8 pages Melt Pharmaceuticals, Inc. Non-Employee Director Deferred Issuance Restricted Stock Unit Grant Notice
12/34/56
EX-10.3
from S-1 19 pages Melt Pharmaceuticals, Inc. Restricted Stock Award Grant Notice
12/34/56
EX-10.2
from S-1 15 pages Melt Pharmaceuticals, Inc. Stock Option Grant Notice
12/34/56
EX-10.1
from S-1 23 pages Melt Pharmaceuticals, Inc. 2018 Equity Incentive Plan Adopted by the Board of Directors: April 15, 2018 Approved by the Stockholders: April 15, 2018 Amended by the Board of Directors: January 30, 2019 Approved by the Stockholders: January 30, 2019 Termination Date: April 15, 2028
12/34/56